Encapsulated Lactoferrin strengthens Natural Defences against COVID

New Delhi: Coronavirus continues to threaten the world, and the number of affected people continues to grow. Faced with this situation, Dr Gabriel Serrano, dermatologist and pioneer in lactoferrin research, is increasing his efforts to contribute to the people’s health and wellbeing through different initiatives. Among them is the development of a complete line of products containing liposomal lactoferrin.

The encapsulation of lactoferrin in liposomes increases its effectiveness in the target cell and increases its stability over time.

Studies indicate that the main mode of transmission for Covid-19 continue to be the droplets exhaled through the airways when coughing, sneezing, singing, or speaking. These droplets may reach the mouth or nose of those nearby and end up in their lungs.  The latest launch to block the entry of the virus is LACTYFERRIN DEFENSE PLUS Nasal Spray, which strengthens the natural barrier of theairways thanks to its formula with liposomal lactoferrin.

Dr Gabriel Serrano, dermatologist with over 45 years of professional experience, has carried out several studies on the usefulness of lactoferrin in prevention and treatment of Covid-19-affected patients. Lactoferrin is a milk-derived multifunctional protein, although it is also present in mucous secretions (tears and saliva, among others). Thus, the extensive studies performed conclude that lactoferrin forms part of the organism’s natural shield, and plays a very important role in innate immunity. It is the link to adaptive immunity.

  • Related Posts

    Pain is passé in Blood Test, thanks to Metropolis’ Human Touch

    New Delhi: Blood drawing for test has really reached proverbial ant bite, thanks to introduction of innovative blood collection technology by Metropolis healthcare, India’s second largest pathology laboratory chain. First…

    60 Countries witnessed AMTZ, Seed of Global Hub of Medical Devices

    Vishakhapatnam: It could be the beginning of the end of dependence of India on imports of medical devices. Import lobby must have watched this gathering of 60 countries to witness…

    Leave a Reply

    Your email address will not be published. Required fields are marked *

    You Missed

    Healthcare, pharma sectors raise Rs 14,811 crore via IPOs in 2024

    Healthcare, pharma sectors raise Rs 14,811 crore via IPOs in 2024

    NPPA sets retail prices for 65 drugs, revises ceiling for 20 formulations

    NPPA sets retail prices for 65 drugs, revises ceiling for 20 formulations

    India-Latin America trade and collaboration prospects discussed at Kerala University conference

    India-Latin America trade and collaboration prospects discussed at Kerala University conference

    Karnataka Govt Files Criminal Cases Against Pharma Firm In Ballari Maternal Deaths Case

    Karnataka Govt Files Criminal Cases Against Pharma Firm In Ballari Maternal Deaths Case

    NPPA Notifies Ceiling Price Of 13 Formulations, Retail Price Of 65 New Drugs

    NPPA Notifies Ceiling Price Of 13 Formulations, Retail Price Of 65 New Drugs

    Over 14,000 PMBJK Centres Set Up To Provide Generic Medicines: Govt

    Over 14,000 PMBJK Centres Set Up To Provide Generic Medicines: Govt